Biologics and Small-Molecule Inhibitors in Nummular Dermatitis: A Systematic Review

Abstract

Keywords

nummular dermatitis nummular eczema dupilumab tralokinumab guselkumab

Get full access to this article

View all access options for this article.

References

Böhner

Jargosch

Müller

, et al. The neglected twin: nummular eczema is a variant of atopic dermatitis with codominant T_H2/T_H17 immune response. J Allergy Clin Immunol. 2023;152(2):408-419. doi:10.1016/j.jaci.2023.04.009

Koskeridis

Evangelou

Ntzani

Kostikas

Tsabouri

Treatment with dupilumab in patients with atopic dermatitis: systematic review and meta-analysis. J Cutan Med Surg. 2022;26(6):613-621. doi:10.1177/12034754221130969

Simpson

Bieber

Guttman-Yassky

, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335-2348. doi:10.1056/NEJMoa1610020

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.05 MB

0.03 MB

0.04 MB

0.02 MB